Trellus Health (TRLS)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.91p
   
  • Change Today:
    -0.041p
  • 52 Week High: 5.75
  • 52 Week Low: 0.90
  • Currency: UK Pounds
  • Shares Issued: 161.51m
  • Volume: 53,786
  • Market Cap: £1.47m

Trellus Health Overview

Trellus Health is commercialising the provision of digital chronic condition management solutions for employers and health plans that utilise the scientifically validated GRITT™ resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate™ to coordinate and deliver care remotely via telemedicine. The Company is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis, but considers its approach to have potential utility and demand across many chronic conditions.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -35805.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 106.0 n/a
Pr/Book 0.1  
Latest F'cast
Revenue 5.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Trellus Health Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (0.76) (1.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.03 (5.90) (0.04)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.02 (8.81) (0.05)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 0.02 (6.34) (0.04)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Trellus Health Company Announcements

Holding(s) in Company 30-Sep-2024 07:00 RNS
Half-year Report 26-Sep-2024 07:00 RNS
Directorate Change 19-Sep-2024 07:00 RNS

Latest Trellus Health Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Trellus Health Market Data

Currency UK Pounds
Share Price 0.91p
Change Today -0.041p
% Change -4.33 %
52 Week High 5.75
52 Week Low 0.90
Volume 53,786
Shares Issued 161.51m
Market Cap £1.47m

Trellus Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.76% above the market average45.76% above the market average45.76% above the market average45.76% above the market average45.76% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average
Price Trend
93.91% below the market average93.91% below the market average93.91% below the market average93.91% below the market average93.91% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Trellus Health Dividends

No dividends found

Trades for 04-Oct-2024

Time Volume / Share Price
14:17 1,315 @ 0.91p
11:22 94 @ 0.91p
08:23 52,377 @ 0.95p

Trellus Health Key Personnel

CEO Marla Dubinsky

Top of Page